Taher Modarressi, M.D.(@tmodarressi) 's Twitter Profile Photo

Fascinating study of icosapent ethyl (Vascepa) in COVID-19 (CardioLink-9) by Dr. Deepak L. Bhatt at . Impressive results, and intriguing to consider other TG-independent, inflammation-targeting uses, such as in ACS or CABG (+loading dose!), or even parts of the oncology world.

Fascinating study of icosapent ethyl (Vascepa) in COVID-19 (CardioLink-9) by @DLBHATTMD at #NLASessions. Impressive results, and intriguing to consider other TG-independent, inflammation-targeting uses, such as in ACS or CABG (+loading dose!), or even parts of the oncology world.
account_circle
Katherine Wilemon(@KAWilemon) 's Twitter Profile Photo

David Wald’s stellar presentation of his Child-Parent screening study during routine immunization. Number needed to screen 125 to identify 1 FH individual. “Children benefit twice, individual prevention of heart disease and appropriate treatment of parents.”

#NLASessions David Wald’s stellar presentation of his Child-Parent screening study during routine immunization. Number needed to screen 125 to identify 1 FH individual. “Children benefit twice, individual prevention of heart disease and appropriate treatment of parents.” #knowFH
account_circle
Joe Nardolillo, PharmD, BCACP(@JoeNardolillo_) 's Twitter Profile Photo

Great experience presenting my residency research project “Statin prescribing for primary prevention of ASCVD among people living with HIV”. Thanks to all of my mentors and co-investigators for your support! National Lipid Association

Great experience presenting my residency research project “Statin prescribing for primary prevention of ASCVD among people living with HIV”. Thanks to all of my mentors and co-investigators for your support! #NLASessions @nationallipid
account_circle
NewAmsterdam Pharma(@NewAmsPharma) 's Twitter Profile Photo

We are pleased to announce the release of the results from our Phase 2 ROSE 2 clinical trial. This afternoon, we're presenting the full data in a late-breaking session at @NationalLipid's . bit.ly/3PbwaZR

We are pleased to announce the release of the results from our Phase 2 ROSE 2 clinical trial. This afternoon, we're presenting the full data in a late-breaking session at @NationalLipid's #NLASessions. bit.ly/3PbwaZR
account_circle